Challenges and Priorities for Children With Congenital Valvar Heart Disease: The Heart Valve Collaboratory
This summary document reviews the current state of valve therapy for pediatric and congenital heart disease patients and the needs being addressed for continued valve development.
ACHD Heart Failure Innovation Summit: Define, Prevent, Treat, Support Workshop [Sneak Peek]
FDA: What Will it Take to Design a Device Regulatory Trial for this Population — Gavin D’Souza
Understanding Failure of Adult and Pediatric Heart Valve Substitutes
In this session, Dr. Frederick Schoen, M.D., Ph.D., Professor of Pathology and Health Sciences and Technology (HST), Brigham and Women’s Hospital and Harvard Medical School will provide insights on the characteristics and mechanisms of failure of mechanical, bioprosthetic and other tissue heart valve substitutes used in adult and pediatric patients.
Novel Polymeric Materials Intended for Use in Heart Valve Applications
In this session, Jim Runt, PhD and Ryan Stanfield, PhD will provide insights on the potential for polymer heart valves in general as well as how current challenges associated with pediatric heart valve options can be addressed.
PTFE 101 – Covering the Basics of this Unique Material
During this informative session, Dr. James Chang, WL Gore & Associates, Inc. will provide background and insights on the unique properties of PTFE with consideration to its use in heart valve applications.
In Vivo Assessment of Novel Cardiac Valve Prostheses Intended for Pediatric Use
During this informative session, Dr. John P. Carney, PhD, MBA, Director – Experimental Surgical Services (ESS) Laboratory, Assistant Professor – University of Minnesota Department of Surgery will provide insights on the use of large animal models to advance novel pediatric valve technology into clinical investigation.
A Clinician’s Perspective on Current Therapies and Unmet Needs for Congenital Heart Valve Patients
During this informative session, Dr. Eric Feins, M.D., Congenital Heart Surgeon, Boston Children’s Hospital will provide valuable insights on the current therapies for congenital heart valve patients, along with a discussion on the unmet needs in this specialized field.